Publikationen in Zusammenarbeit mit Forschern von Universitat Autònoma de Barcelona (9)

2022

  1. Calcitonin gene–related peptide in migraine: from pathophysiology to treatment

    Neurologia, Vol. 37, Núm. 5, pp. 390-402

  2. Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients

    Cephalalgia, Vol. 42, Núm. 8, pp. 804-809

2021

  1. Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance

    Journal of Headache and Pain, Vol. 22, Núm. 1

  2. Document of revision and updating of medication overuse headache (MOH)

    Neurologia, Vol. 36, Núm. 3, pp. 229-240

  3. Persistent headache after COVID-19: Pathophysioloy, clinic and treatment

    Neurology Perspectives, Vol. 1, pp. S31-S36

2020

  1. Evaluation of the concomitant use of oral preventive treatments and onabotulinumtoxinA in chronic migraine: the PREVENBOX study

    European Journal of Neurology, Vol. 27, Núm. 10, pp. 2102-2108

  2. Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine

    Neurologia, Vol. 35, Núm. 8, pp. 568-578

  3. Specialised headache units, a feasible alternative in Spain

    Revista de Neurologia, Vol. 71, Núm. 6, pp. 199-204

2019

  1. Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice

    Neurologia, Vol. 34, Núm. 6, pp. 408-417